These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9000251)

  • 1. Substitution of peptide bond 53-54 of HEL(52-61) with an ethylene bond rather than reduced peptide bond is tolerated by an MHC-II restricted T cell.
    Ettouati L; Salvi JP; Trescol-Biémont MC; Walchshofer N; Gerlier D; Rabourdin-Combe C; Paris J
    Pept Res; 1996; 9(5):248-53. PubMed ID: 9000251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-dominant restriction by a mixed-haplotype I-A molecule (alpha k beta b) for the lysozyme peptide 52-61 in H-2k x H-2b F1 mice.
    Moreno J; Adorini L; Hämmerling GJ
    J Immunol; 1990 May; 144(9):3296-304. PubMed ID: 1970351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin D, but not cathepsin B, releases T cell stimulatory fragments from lysozyme that are functional in the context of multiple murine class II MHC molecules.
    van Noort JM; Jacobs MJ
    Eur J Immunol; 1994 Sep; 24(9):2175-80. PubMed ID: 8088334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Processing of endogenously synthesized hen egg-white lysozyme retained in the endoplasmic reticulum or in secretory form gives rise to a similar but not identical set of epitopes recognized by class II-restricted T cells.
    Adorini L; Guéry JC; Fuchs S; Ortiz-Navarrete V; Hämmerling GJ; Momburg F
    J Immunol; 1993 Oct; 151(7):3576-86. PubMed ID: 7690807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the interaction of peptide hen egg white lysozyme (34-45) with the I-Ak molecule.
    Lambert LE; Unanue ER
    J Immunol; 1989 Aug; 143(3):802-7. PubMed ID: 2787347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the T-cell and Ia contact residues of a T-cell antigenic epitope.
    Allen PM; Matsueda GR; Evans RJ; Dunbar JB; Marshall GR; Unanue ER
    Nature; 1987 Jun 25-Jul 1; 327(6124):713-5. PubMed ID: 2439915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of T cell reactivities to phosphorylcholine-conjugated hen egg lysozyme in C57BL/6 mice: hapten-conjugate specificity reflects an altered expression of a major carrier epitope.
    Jang YS; Lim KH; Kim BS
    Eur J Immunol; 1991 May; 21(5):1303-10. PubMed ID: 1709872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expressed T cell repertoire is hierarchical: the precise focus of lysozyme-specific T cell clones is dependent upon the structure of the immunogen.
    Shastri N; Miller A; Sercarz EE
    J Mol Cell Immunol; 1984; 1(6):369-79. PubMed ID: 6086045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen presentation by dendritic cells focuses T cell responses against immunodominant peptides: studies in the hen egg-white lysozyme (HEL) model.
    Gapin L; Bravo de Alba Y; Casrouge A; Cabaniols JP; Kourilsky P; Kanellopoulos J
    J Immunol; 1998 Feb; 160(4):1555-64. PubMed ID: 9469410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinant selection for T-cell tolerance in HEL-transgenic mice: dissociation between immunogenicity and tolerogenicity.
    Gapin L; Cabaniols JP; Cibotti R; Ojcius DM; Kourilsky P; Kanellopoulos JM
    Cell Immunol; 1997 Apr; 177(1):77-85. PubMed ID: 9140098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding to Ia protects an immunogenic peptide from proteolytic degradation.
    Donermeyer DL; Allen PM
    J Immunol; 1989 Feb; 142(4):1063-8. PubMed ID: 2783704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation.
    Guéry JC; Sette A; Leighton J; Dragomir A; Adorini L
    J Exp Med; 1992 May; 175(5):1345-52. PubMed ID: 1569402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a naturally processed MHC class II-restricted T-cell determinant of hen egg lysozyme.
    Demotz S; Grey HM; Appella E; Sette A
    Nature; 1989 Dec; 342(6250):682-4. PubMed ID: 2480524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-terminal extension of the MHC class II-associated invariant chain by an antigenic sequence triggers activation of naive T cells.
    Sponaas A; Carstens C; Koch N
    Gene Ther; 1999 Nov; 6(11):1826-34. PubMed ID: 10602378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo T helper cell response to retro-inverso peptidomimetics.
    Mézière C; Viguier M; Dumortier H; Lo-Man R; Leclerc C; Guillet JG; Briand JP; Muller S
    J Immunol; 1997 Oct; 159(7):3230-7. PubMed ID: 9317121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complexes generated by the binding of free peptides to class II MHC molecules are antigenically diverse compared with those generated by intracellular processing.
    Viner NJ; Nelson CA; Deck B; Unanue ER
    J Immunol; 1996 Apr; 156(7):2365-8. PubMed ID: 8786292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells.
    Robson NC; Donachie AM; Mowat AM
    Eur J Immunol; 2008 May; 38(5):1238-46. PubMed ID: 18398931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
    J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can one predict antigenic peptides for MHC class I-restricted cytotoxic T lymphocytes useful for vaccination?
    Calin-Laurens V; Trescol-Biémont MC; Gerlier D; Rabourdin-Combe C
    Vaccine; 1993; 11(9):974-8. PubMed ID: 7692684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.